What is Edwards Lifesciences's change in AP?

Edwards Lifesciences (EW) reported change in AP of -$347.1M in Q1 2026.

How has Edwards Lifesciences's change in AP changed year-over-year?

Edwards Lifesciences's change in AP decreased by 235.7% year-over-year, from -$103.4M to -$347.1M.

What is the long-term trend for Edwards Lifesciences's change in AP?

Over 3 years (2021 to 2025), Edwards Lifesciences's change in AP has grown at a 26.5% compound annual growth rate (CAGR), from $195.2M to $395.1M.

What does change in AP mean?

Increase or decrease in amounts owed to suppliers — a key working capital component affecting operating cash flow.

Edwards Lifesciences EW Change in AP

Change in AP at other companies

ArtivionAORT

-$8.7M+45.8%

Merit Medical SystemsMMSI

$4.49M+0.9%

ICU MedicalICUI

$20.15M-37.2%

Boston ScientificBSX

-$512M-33.0%

LeMaitre VascularLMAT

-$2.34M+55.5%

MedtronicMDT

$123M-66.4%

Other financials

Income statement

See full

Revenue$1.6B+16.7%

Gross profit$1.3B+15.7%

Operating income$477.6M+21.0%

Net income$380.7M+6.3%

EPS (diluted)$0.66+8.2%

Balance sheet

See full

Cash & equivalents$2.4B-22.3%

Total debt$702.9M+0.5%

Total equity$10.3B+2.0%

Total assets$13.3B+2.3%

Cash flow

See full

Operating cash flow$43.8M-84.4%

CapEx$64.9M+15.9%

Free cash flow-$21.1M-109%

Valuation

See full

Market cap$52.09B+20.1%

Enterprise value$50.34B+23.3%

P/E47.5×+37.1×

P/S8.3×+0.6×

Profitability

See full

Gross margin77.9%-1.6pp

Operating margin21.4%-4.4pp

Net margin17.4%-58.3pp

FCF margin17.3%—

Returns & leverage

See full

Return on equity10.7%-37.8pp

Debt / equity0.1×0.0×

Current ratio4.4×0.0×

Where this comes from

Reported directly by Edwards Lifesciences in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities.

The official record: Edwards Lifesciences’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Edwards Lifesciences's change in ap.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Edwards Lifesciences's change in AP?: Edwards Lifesciences (EW) reported change in AP of -$347.1M in Q1 2026.
How has Edwards Lifesciences's change in AP changed year-over-year?: Edwards Lifesciences's change in AP decreased by 235.7% year-over-year, from -$103.4M to -$347.1M.
What is the long-term trend for Edwards Lifesciences's change in AP?: Over 3 years (2021 to 2025), Edwards Lifesciences's change in AP has grown at a 26.5% compound annual growth rate (CAGR), from $195.2M to $395.1M.
What does change in AP mean?: Increase or decrease in amounts owed to suppliers — a key working capital component affecting operating cash flow.